Indaptus Therapeutics, Inc. INDP
3.85
(0.15)
(3.75%)
as of 25 Sep
- Market cap
- $606.8M
- P/E
- 0.0×
Follow INDP
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
1.51 | 1.95 | 5.05 | 7.94 | 8.77 | 0.86 | 1.65 | 5.69 | 9.80 | 10.77 |
Net Debt/EBITDA |
0.43 | 0.38 | 0.82 | 1.77 | 5.06 | 0.46 | 0.22 | 0.96 | 1.93 | 1.39 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.71 | 0.82 | 0.87 | 0.91 | 1.46 | 0.93 | 0.61 | 0.90 | 0.77 | 0.90 |
Capex/Depreciation |
— | 0.00 | 0.00 | 0.00 | (2.79) | (24.44) | (1.08) | (5.43) | (6.02) | (0.69) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (588.41%) | (187.52%) | (84.04%) | (47.32%) | (43.26%) | (63.50%) | (146.28%) | (77.52%) | (70.94%) | (45.89%) | |
| (250.45%) | (134.95%) | (71.76%) | (41.73%) | (36.41%) | (31.09%) | (114.99%) | (69.08%) | (64.77%) | (43.18%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (1,998.85%) | (208.85%) | (513.38%) | (192.86%) |
Return on Tangible Assets |
(661.53%) | (465.89%) | (137.44%) | (60.15%) | (21.55%) | 1,270.09% | (596.63%) | (90.45%) | (49.16%) | (58.60%) |
Average Days of Receivables |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(15.34) | (36.88) | (44.70) | (44.33) | (77.36) | (48.22) | (1,984.50) | (3,146.98) | (3,433.67) | (2,448.43) |
Cash per Share |
8.81 | 17.32 | 44.56 | 89.60 | 268.03 | 23.60 | 666.36 | 2,919.35 | 6,989.62 | 3,574.12 |
Shareholders Equity per Share |
3.26 | 11.81 | 40.27 | 83.49 | 245.89 | (3.43) | 763.91 | 3,852.16 | 7,443.29 | 4,451.76 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
3.26 | 11.81 | 40.27 | 83.49 | 245.89 | (3.43) | 763.91 | 3,852.16 | 7,443.29 | 4,451.76 |
Free Cash Flow |
(14.82) | (12.32) | (13.41) | (13.08) | (11.29) | (3.35) | (29.97) | (43.74) | (27.13) | (12.49) |
Working Capital |
3.15 | 3.22 | 11.22 | 23.81 | 35.78 | (0.28) | 5.40 | 35.91 | 50.60 | 18.75 |
Capital Expenditures |
— | — | — | — | 0.00 | (0.02) | (0.92) | (4.67) | (4.99) | (0.48) |
Net Current Asset Value |
3.15 | 3.22 | 11.15 | 23.81 | 35.71 | (0.28) | 4.00 | 35.60 | 50.60 | 18.66 |
| Other line items | ||||||||||
Quick Ratio |
1.38 | 1.71 | 4.82 | 7.70 | 8.50 | 0.85 | 1.65 | 5.69 | 9.80 | 10.74 |
Depreciation/Fixed assets |
— | 0.00 | 1.86 | 0.90 | 0.37 | 0.69 | 0.33 | 0.07 | 0.10 | 0.17 |
Cash ROIC |
(127.14%) | (126.63%) | (52.70%) | (25.62%) | (15.05%) | (237.60%) | (146.41%) | (54.51%) | (26.61%) | (39.22%) |
Accounts Receivable Turnover |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(15.34) | (36.88) | (44.70) | (44.33) | (77.33) | (47.90) | (1,923.51) | (2,811.22) | (2,801.52) | (2,353.92) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | (0.03) | (0.32) | (60.99) | (335.76) | (632.15) | (94.51) |
Average Receivables |
— | — | — | — | 0.05 | 1.88 | 3.33 | 2.06 | 1.75 | 2.37 |
Average Payables |
4.73 | 2.99 | 3.01 | 3.93 | 2.55 | 2.05 | 3.18 | 2.35 | 1.50 | 0.88 |
Average Assets |
8.32 | 11.13 | 21.49 | 34.32 | 21.18 | 11.53 | 41.40 | 63.03 | 44.64 | 30.95 |
Average Common Equity |
3.54 | 8.01 | 18.35 | 30.27 | 17.83 | 5.64 | 32.54 | 56.17 | 40.75 | 29.12 |
Capex to Sales |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates